EKF Stock Overview
Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
EKF Diagnostics Holdings plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.25 |
| 52 Week High | UK£0.34 |
| 52 Week Low | UK£0.23 |
| Beta | 0.59 |
| 1 Month Change | 1.00% |
| 3 Month Change | -9.98% |
| 1 Year Change | -10.14% |
| 3 Year Change | -67.88% |
| 5 Year Change | -26.92% |
| Change since IPO | -39.16% |
Recent News & Updates
Recent updates
An Intrinsic Calculation For EKF Diagnostics Holdings plc (LON:EKF) Suggests It's 34% Undervalued
Jul 11
EKF Diagnostics Holdings' (LON:EKF) Solid Earnings Have Been Accounted For Conservatively
Mar 27EKF Diagnostics Holdings plc (LON:EKF) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 23These 4 Measures Indicate That EKF Diagnostics Holdings (LON:EKF) Is Using Debt Reasonably Well
Mar 21EKF Diagnostics Holdings plc's (LON:EKF) Low P/S No Reason For Excitement
Jan 31EKF Diagnostics Holdings plc (LON:EKF) Shares Could Be 44% Below Their Intrinsic Value Estimate
Dec 22EKF Diagnostics Holdings plc (LON:EKF) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jul 01Calculating The Fair Value Of EKF Diagnostics Holdings plc (LON:EKF)
Mar 30At UK£0.44, Is It Time To Put EKF Diagnostics Holdings plc (LON:EKF) On Your Watch List?
Jan 31What Does EKF Diagnostics Holdings plc's (LON:EKF) Share Price Indicate?
Oct 06Here's Why We Think EKF Diagnostics Holdings (LON:EKF) Might Deserve Your Attention Today
Aug 16Some EKF Diagnostics Holdings plc (LON:EKF) Analysts Just Made A Major Cut To Next Year's Estimates
Apr 14Downgrade: Here's How Analysts See EKF Diagnostics Holdings plc (LON:EKF) Performing In The Near Term
Mar 31An Intrinsic Calculation For EKF Diagnostics Holdings plc (LON:EKF) Suggests It's 33% Undervalued
Nov 29Investors Will Want EKF Diagnostics Holdings' (LON:EKF) Growth In ROCE To Persist
May 11A Look At The Fair Value Of EKF Diagnostics Holdings plc (LON:EKF)
Apr 20EKF Diagnostics Holdings plc Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next
Apr 02Rainbows and Unicorns: EKF Diagnostics Holdings plc (LON:EKF) Analysts Just Became A Lot More Optimistic
Mar 31EKF Diagnostics Holdings plc's (LON:EKF) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Mar 09EKF Diagnostics Holdings (LON:EKF) Has Rewarded Shareholders With An Exceptional 804% Total Return On Their Investment
Feb 17At UK£0.72, Is EKF Diagnostics Holdings plc (LON:EKF) Worth Looking At Closely?
Jan 26What Do The Returns On Capital At EKF Diagnostics Holdings (LON:EKF) Tell Us?
Jan 06Is EKF Diagnostics Holdings plc (LON:EKF) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 19EKF Diagnostics Holdings plc (LON:EKF) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Dec 01
Shareholder Returns
| EKF | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 1.8% | -2.0% | -1.4% |
| 1Y | -10.1% | -7.9% | 4.6% |
Return vs Industry: EKF underperformed the UK Medical Equipment industry which returned -6.6% over the past year.
Return vs Market: EKF underperformed the UK Market which returned 17.5% over the past year.
Price Volatility
| EKF volatility | |
|---|---|
| EKF Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: EKF has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: EKF's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 309 | n/a | www.ekfdiagnostics.com |
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; Ultracrit, a hematocrit device; DiaSpect Hemoglobin T analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer.
EKF Diagnostics Holdings plc Fundamentals Summary
| EKF fundamental statistics | |
|---|---|
| Market cap | UK£114.57m |
| Earnings (TTM) | UK£4.78m |
| Revenue (TTM) | UK£50.95m |
24.0x
P/E Ratio2.2x
P/S RatioIs EKF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKF income statement (TTM) | |
|---|---|
| Revenue | UK£50.95m |
| Cost of Revenue | UK£26.47m |
| Gross Profit | UK£24.48m |
| Other Expenses | UK£19.71m |
| Earnings | UK£4.78m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 48.05% |
| Net Profit Margin | 9.37% |
| Debt/Equity Ratio | 0% |
How did EKF perform over the long term?
See historical performance and comparisonDividends
4.8%
Current Dividend Yield114%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 05:32 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EKF Diagnostics Holdings plc is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Julie Simmonds | Canaccord Genuity |
| Julie Simmonds | Collins Stewart plc |
| Jens Lindqvist | Investec Bank plc (UK) |